See below for a list of our latest prescribing data reports, evidence reviews, and other publications. If you’re looking for something in particular, please use the search function or get in touch at nuth.nyrdtc.rxsupp@nhs.net.

For a summary of work in progress, see our forthcoming publications.

New and recent publications
Formulary assessment – Melatonin (Ceyesto) 1mg/ml oral solution
Monthly Horizon Scanning Report – February 2024
Monthly formulary amendments – January 2024
Comparison of DOACs for Atrial Fibrillation
Monthly Horizon Scanning Report – January 2024
Monthly formulary amendments – December 2023
Annual Horizon Scanning Report – 2024-2025
Monthly Horizon Scanning Report – December 2023
Prescribing Update Newsletter – December 2023
Monthly formulary amendments – November 2023
NHS Medicines Optimisation Opportunities Dashboard 2023-24
Monthly Horizon Scanning Report – November 2023
Monthly Formulary Amendments – October 2023
Monthly Horizon Scanning Report – October 2023
Prescribing Update Newsletter – September 2023
Monthly Formulary Amendments – September 2023
Defining the type-2 diabetic population: a first step to understanding the impact of pathway choices
Budget impact of paracetamol 250mg/5ml oral suspension
Budget impact of emollient bath and shower preparations
Monthly Horizon Scanning Report – September 2023
Monthly Formulary Amendments – August 2023
Sustainability: Environmental impact of inhaler disposal
Budget impact of acetylcysteine vs carbocisteine
Budget impact of promethazine prescribing
Monthly Formulary Amendments – July 2023
Monthly Horizon Scanning Report – August 2023
Transfer of prescribing from private provider to NHS GP
Budget impact of methylphenidate modified release tablet choice
Monthly Formulary Amendments – June 2023
Monthly Horizon Scanning Report – July 2023
Prescribing Update Newsletter – July 2023
Monthly Horizon Scanning Report – June 2023
Monthly Formulary Amendments – May 2023
Monthly Horizon Scanning Report – May 2023
Monthly Formulary Amendments – April 2023
What are the statutory obligations of an ICS for the implementation of NICE guidance
Formulary assessment – Otinova ear spray for otitis externa
Prescribing Update Newsletter – April 2023
Monthly Horizon Scanning Report – April 2023
Monthly Formulary Amendments – February 2023
Monthly Formulary Amendments – March 2023
Monthly Horizon Scanning Report – March 2023
Considerations for Sustainable Inhaler Prescribing
NICE TA875; Semaglutide for managing obesity: A briefing for ICSs  
Formulary assessment – Tacalcitol (Curatoderm) Lotion and Ointment
Problematic Polypharmacy:  Prescribing Cascades Evidence Evaluation
Prescribing Update Newsletter – February 2023
Monthly Horizon Scanning Report – February 2023
Monthly Formulary Amendments – January 2023
Polypharmacy & Overprescribing: Opioid population health management
Polypharmacy & Overprescribing: Opioid patient demographics
Polypharmacy & Overprescribing: Opioid patient populations
Budget impact of metformin 1g immediate release tablet prescribing